• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19.

作者信息

Kow Chia Siang, Hasan Syed Shahzad

机构信息

School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.

School of Applied Sciences, University of Huddersfield, Huddersfield, UK.

出版信息

J Thromb Thrombolysis. 2021 Jan;51(1):29-30. doi: 10.1007/s11239-020-02200-w.

DOI:10.1007/s11239-020-02200-w
PMID:32596786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7321015/
Abstract
摘要

相似文献

1
Pharmacologic therapeutic options for thromboprophylaxis in COVID-19.2019冠状病毒病血栓预防的药物治疗选择
J Thromb Thrombolysis. 2021 Jan;51(1):29-30. doi: 10.1007/s11239-020-02200-w.
2
Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.COVID-19 住院患者的深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):597-604. doi: 10.1016/j.jvsv.2020.09.010. Epub 2020 Oct 8.
3
Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19.住院 COVID-19 患者中较少不给予药物预防静脉血栓栓塞症。
J Thromb Thrombolysis. 2021 Aug;52(2):471-475. doi: 10.1007/s11239-021-02384-9. Epub 2021 Jan 28.
4
Post-hospital discharge venous thromboembolism prophylaxis in medically ill patients.住院后疾病相关静脉血栓栓塞症预防。
Postgrad Med. 2021 Aug;133(sup1):51-63. doi: 10.1080/00325481.2021.1876387. Epub 2021 Feb 9.
5
Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.3型血管性血友病合并重症新型冠状病毒肺炎感染患者的一级血栓预防
Haemophilia. 2021 Jul;27(4):e517-e519. doi: 10.1111/hae.14252. Epub 2021 Jan 11.
6
The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19.抗血小板药物在新型冠状病毒肺炎动脉血栓预防中的应用。
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):114-115. doi: 10.1016/j.rec.2020.08.009. Epub 2020 Aug 28.
7
COVID-19 and thrombosis: Prophylaxis and management.2019冠状病毒病与血栓形成：预防与管理
Tuberk Toraks. 2021 Jun;69(2):269-278. doi: 10.5578/tt.20219818.
8
A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.时间问题：COVID-19确诊患者静脉血栓预防的持续时间和选择
Br J Hosp Med (Lond). 2020 May 2;81(5):1-2. doi: 10.12968/hmed.2020.0210. Epub 2020 May 18.
9
Venous thromboembolism among patients hospitalized with COVID-19 at Veterans Health Administration Hospitals.COVID-19 住院患者在退伍军人健康管理局医院中的静脉血栓栓塞症。
Am Heart J. 2021 Jul;237:1-4. doi: 10.1016/j.ahj.2021.03.010. Epub 2021 Mar 18.
10
Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?口服抗凝剂的长期治疗能否改善2019冠状病毒病（COVID-19）中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的临床病程？
Semin Thromb Hemost. 2021 Jun;47(4):338-340. doi: 10.1055/s-0040-1715091. Epub 2020 Sep 3.

引用本文的文献

1
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic.新型冠状病毒肺炎大流行期间用于心房颤动患者的直接口服抗凝剂（DOAC）
Med Clin (Engl Ed). 2022 Nov 11;159(9):e61. doi: 10.1016/j.medcle.2022.05.022. Epub 2022 Nov 3.
2
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic.新型冠状病毒肺炎大流行期间心房颤动患者使用直接口服抗凝剂（DOAC）的情况
Med Clin (Barc). 2022 Nov 11;159(9):e61. doi: 10.1016/j.medcli.2022.05.016. Epub 2022 Jul 20.
3
Biologically guided isolation and ADMET profile of new factor Xa inhibitors from roots using and approaches.利用[具体方法1]和[具体方法2]从根部进行生物导向分离及新型Xa因子抑制剂的ADMET特性研究。
RSC Adv. 2021 Mar 9;11(17):9995-10001. doi: 10.1039/d1ra00359c. eCollection 2021 Mar 5.
4
Thromboprophylaxis in COVID-19 - Rationale and considerations.COVID-19 相关的血栓预防——基本原理和注意事项。
Adv Biol Regul. 2021 Aug;81:100819. doi: 10.1016/j.jbior.2021.100819. Epub 2021 Jul 23.

本文引用的文献

1
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.COVID-19 患者接受抗栓治疗时的静脉血栓栓塞症的系统评估：发生率和 D-二聚体作为预测因素的作用。
J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z.
2
COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept.新型冠状病毒肺炎相关凝血病：血栓炎症概念的最高成就。
Anaesth Crit Care Pain Med. 2020 Jun;39(3):381-382. doi: 10.1016/j.accpm.2020.04.013. Epub 2020 May 4.
3
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
4
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI).急性冠脉综合征合并心原性休克或院外心脏骤停患者的抗栓治疗：欧洲心脏病学会（ESC）血栓形成工作组与急性心血管护理协会（ACCA）和欧洲经皮心血管介入协会（EAPCI）联合发布的联合立场文件。
Eur Heart J Cardiovasc Pharmacother. 2021 Mar 15;7(2):125-140. doi: 10.1093/ehjcvp/pvaa009.
5
Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study.利伐沙班用于近期因急性传染病住院患者的血栓预防：MAGELLAN 研究的亚组分析。
J Thromb Haemost. 2018 Jul;16(7):1278-1287. doi: 10.1111/jth.14146. Epub 2018 Jun 21.
6
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.在急性内科疾病患者中使用延长疗程的贝曲西班预防静脉血栓栓塞（APEX）试验中，全剂量与减少剂量贝曲西班的安全性和有效性。
Am Heart J. 2017 Mar;185:93-100. doi: 10.1016/j.ahj.2016.12.004. Epub 2016 Dec 18.
7
Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity.严重急性呼吸综合征冠状病毒刺突蛋白被蛋白酶因子Xa切割与病毒感染性相关。
Biochem Biophys Res Commun. 2007 Jul 20;359(1):174-9. doi: 10.1016/j.bbrc.2007.05.092. Epub 2007 May 22.